Artificial Intelligence (AI) in Life Sciences Market Size, Share & Trends Analysis Report By Technology (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Others), By Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring, Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug), By Drug Type (Small Molecule, Large Molecule), By Offering (Software, Services), By Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Others), By End user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Research Centres And Academic Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Pavan Warade | Format: | Report Code: SR2356DR | Pages: 157

Market Segmentation

  1. Artificial Intelligence (AI) in Life Sciences Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Machine Learning (ML)
    2. Deep Learning (DL)
    3. Natural Language Processing (NLP)
    4. Others
  2. Artificial Intelligence (AI) in Life Sciences Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Drug Discovery
    2. Medical Diagnosis
    3. Biotechnology
    4. Clinical Trials
    5. Precision and Personalized Medicine
    6. Patient Monitoring
    7. Novel Drug Candidates
    8. Drug Optimization and Repurposing Preclinical Testing and Approval
    9. Drug Monitoring
    10.  Finding New Diseases Associated Targets and Pathways
    11.  Understanding Disease Mechanisms
    12.  Aggregating and Synthesizing Information
    13.  Formation & Qualification of Hypotheses
    14.  De Novo Drug Design
    15.  Finding Drug Targets of an Old Drug
  3. Artificial Intelligence (AI) in Life Sciences Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecule
    2. Large Molecule
  4. Artificial Intelligence (AI) in Life Sciences Market, By Offering 2022-2034 (USD MILLION/ Units)
    1. Software
    2. Services
  5. Artificial Intelligence (AI) in Life Sciences Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Immuno-Oncology
    2. Neurodegenerative Diseases
    3. Cardiovascular Diseases
    4. Metabolic Diseases
    5. Others
  6. Artificial Intelligence (AI) in Life Sciences Market, By End user 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology Companies
    2. Contract Research Organizations (CROs)
    3. Research Centres And Academic Institutes
    4. Others
  7. Regional Artificial Intelligence (AI) in Life Sciences Market
    1. North America
      1. North America Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. North America Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. North America Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. North America Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. North America Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. North America Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. U.S. Artificial Intelligence (AI) in Life Sciences Market
        1. U.S. Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. U.S. Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. U.S. Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. U.S. Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. U.S. Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. U.S. Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      8. Canada Artificial Intelligence (AI) in Life Sciences Market
        1. Canada Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Canada Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Canada Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Canada Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Canada Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Canada Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
    2. Europe
      1. Europe Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. Europe Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. Europe Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. Europe Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. Europe Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. Europe Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. U.K. Artificial Intelligence (AI) in Life Sciences Market
        1. U.K. Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. U.K. Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. U.K. Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. U.K. Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. U.K. Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. U.K. Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      8. Germany Artificial Intelligence (AI) in Life Sciences Market
        1. Germany Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Germany Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Germany Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Germany Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Germany Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Germany Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      9. France Artificial Intelligence (AI) in Life Sciences Market
        1. France Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. France Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. France Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. France Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. France Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. France Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      10. Spain Artificial Intelligence (AI) in Life Sciences Market
        1. Spain Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Spain Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Spain Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Spain Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Spain Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Spain Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      11. Italy Artificial Intelligence (AI) in Life Sciences Market
        1. Italy Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Italy Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Italy Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Italy Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Italy Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Italy Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      12. Russia Artificial Intelligence (AI) in Life Sciences Market
        1. Russia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Russia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Russia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Russia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Russia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Russia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      13. Nordic Artificial Intelligence (AI) in Life Sciences Market
        1. Nordic Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Nordic Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Nordic Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Nordic Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Nordic Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Nordic Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      14. Benelux Artificial Intelligence (AI) in Life Sciences Market
        1. Benelux Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Benelux Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Benelux Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Benelux Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Benelux Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Benelux Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      15. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market
        1. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Rest of Europe Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
    3. APAC
      1. APAC Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. APAC Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. APAC Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. APAC Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. APAC Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. APAC Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. China Artificial Intelligence (AI) in Life Sciences Market
        1. China Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. China Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. China Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. China Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. China Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. China Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      8. Korea Artificial Intelligence (AI) in Life Sciences Market
        1. Korea Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Korea Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Korea Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Korea Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Korea Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Korea Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      9. Japan Artificial Intelligence (AI) in Life Sciences Market
        1. Japan Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Japan Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Japan Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Japan Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Japan Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Japan Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      10. India Artificial Intelligence (AI) in Life Sciences Market
        1. India Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. India Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. India Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. India Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. India Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. India Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      11. Australia Artificial Intelligence (AI) in Life Sciences Market
        1. Australia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Australia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Australia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Australia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Australia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Australia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      12. Taiwan Artificial Intelligence (AI) in Life Sciences Market
        1. Taiwan Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Taiwan Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Taiwan Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Taiwan Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Taiwan Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Taiwan Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      13. South East Asia Artificial Intelligence (AI) in Life Sciences Market
        1. South East Asia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. South East Asia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. South East Asia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. South East Asia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. South East Asia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. South East Asia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      14. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market
        1. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Rest of Asia-Pacific Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
    4. Middle East and Africa
      1. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. UAE Artificial Intelligence (AI) in Life Sciences Market
        1. UAE Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. UAE Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. UAE Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. UAE Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. UAE Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. UAE Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      8. Turkey Artificial Intelligence (AI) in Life Sciences Market
        1. Turkey Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Turkey Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Turkey Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Turkey Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Turkey Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Turkey Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      9. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market
        1. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Saudi Arabia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      10. South Africa Artificial Intelligence (AI) in Life Sciences Market
        1. South Africa Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. South Africa Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. South Africa Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. South Africa Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. South Africa Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. South Africa Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      11. Egypt Artificial Intelligence (AI) in Life Sciences Market
        1. Egypt Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Egypt Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Egypt Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Egypt Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Egypt Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Egypt Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      12. Nigeria Artificial Intelligence (AI) in Life Sciences Market
        1. Nigeria Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Nigeria Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Nigeria Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Nigeria Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Nigeria Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Nigeria Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      13. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market
        1. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Rest of MEA Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
    5. LATAM
      1. LATAM Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. LATAM Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. LATAM Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. LATAM Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. LATAM Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. LATAM Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. Brazil Artificial Intelligence (AI) in Life Sciences Market
        1. Brazil Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Brazil Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Brazil Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Brazil Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Brazil Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Brazil Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      8. Mexico Artificial Intelligence (AI) in Life Sciences Market
        1. Mexico Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Mexico Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Mexico Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Mexico Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Mexico Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Mexico Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      9. Argentina Artificial Intelligence (AI) in Life Sciences Market
        1. Argentina Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Argentina Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Argentina Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Argentina Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Argentina Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Argentina Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      10. Chile Artificial Intelligence (AI) in Life Sciences Market
        1. Chile Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Chile Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Chile Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Chile Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Chile Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Chile Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      11. Colombia Artificial Intelligence (AI) in Life Sciences Market
        1. Colombia Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Colombia Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Colombia Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Colombia Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Colombia Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Colombia Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
      12. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market
        1. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Machine Learning (ML)
          2. Deep Learning (DL)
          3. Natural Language Processing (NLP)
          4. Others
        2. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
          1. Drug Discovery
          2. Medical Diagnosis
          3. Biotechnology
          4. Clinical Trials
          5. Precision and Personalized Medicine
          6. Patient Monitoring
          7. Novel Drug Candidates
          8. Drug Optimization and Repurposing Preclinical Testing and Approval
          9. Drug Monitoring
          10.  Finding New Diseases Associated Targets and Pathways
          11.  Understanding Disease Mechanisms
          12.  Aggregating and Synthesizing Information
          13.  Formation & Qualification of Hypotheses
          14.  De Novo Drug Design
          15.  Finding Drug Targets of an Old Drug
        3. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
          1. Small Molecule
          2. Large Molecule
        4. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
          1. Software
          2. Services
        5. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Immuno-Oncology
          2. Neurodegenerative Diseases
          3. Cardiovascular Diseases
          4. Metabolic Diseases
          5. Others
        6. Rest of LATAM Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical & Biotechnology Companies
          2. Contract Research Organizations (CROs)
          3. Research Centres And Academic Institutes
          4. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: